ArticleDrugs & aging2021
Ghent Older People's Prescriptions Community Pharmacy Screening (GheOP
Article in Drugs & aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 26 citations in OpenAlex.
- A scoping review of quality prescribing indicators, rules and criteria for primary care.British journal of clinical pharmacology · 2026Article
- Development and Validation of Prescribing Appropriateness Criteria (PAC) for Sri Lankan Older Adults.Drugs & aging · 2026Article
- Evaluating an integrated clinical pharmacist model in a geriatric day hospital: a prospective single-centre observational study.International journal of clinical pharmacy · 2025Observational
- Implementation of medication review type 2a in community pharmacies: a longitudinal survey study.Frontiers in pharmacology · 2025Article
- The missing link? Pharmacists' perspectives on discontinuation of long-term antidepressants: a qualitative study.Therapeutic advances in psychopharmacology · 2025Article
- Use of the BRANT-MERQS scoring table for the quality assessment of type 3 medication review in patients with rheumatoid arthritis and those with type 2 diabetes mellitus.Frontiers in pharmacology · 2024Article
- Potentially inappropriate medicine use and predicting risk factors in hospitalized older adult patients: findings of a prospective observational study from Ethiopia.Journal of pharmaceutical policy and practice · 2023Article
- Therapeutic dilemmas with benzodiazepines and Z-drugs: insomnia and anxiety disorders versus increased fall risk: a clinical review.European geriatric medicine · 2023Review
- Key elements in the quality assessment of a type 3 medication review.Frontiers in pharmacology · 2023Article
- Potentially clinically significant drug-drug interactions in older patients admitted to the hospital: A cross-sectional study.Frontiers in pharmacology · 2023Article
- Development and consensus testing of quality indicators for geriatric pharmacotherapy in primary care using a modified Delphi study.International journal of clinical pharmacy · 2022Article
- Identifying Potential Drug-Related Problems Among Geriatric Patients With Use of an Integrated Clinical Decision Support Tool.Frontiers in pharmacology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Ghent Older People's Prescriptions community Pharmacy Screening (GheOP
objectiveThis study aimed to revise and update the GheOP
methodsUsers' comments were collected to improve the usability and appropriateness of the original GheOP
resultsThe updated GheOP
conclusionGheOP
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.